FDA Inspection 1038629 — Shift Labs Inc

Shift Labs Inc — FEI 3011567364

The FDA completed an inspection of Shift Labs Inc on Jan 25, 2018 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 25, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Seattle, WA (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.